Archives: Agenda

AI is powerful, but the drug and the patient come first. This boardroom explores how teams can leverage AI safely, integrate it into workflows, and maintain human control with strong processes.

Shift from “random prompting” to building Structured Supply Chain AI Workflows that save hours while keeping human oversight and data security intact

Outcome: Each table will collaborate to create practical strategies, and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.

AI with a Human Touch: Practical Strategies for Smart, Safe Adoption

📊 LIVE POLL

• How to safeguard temperature-sensitive biologics and advanced therapies during shipping delays
• How to stay compliant with local and global regulations while maintaining chain-custody
• How to select validated storage facilities for all temperature ranges while keeping inventory visible and minimizing loss

• How to align CDMO partnerships with phase-specific needs while staying agile
• How to collaborate across CDMOs and ensure smooth tech transitions, especially for biologics therapies
• How to build transparent CDMO partnerships from Day 1 to overcome challenges and save costs

Moderator: Amanda Murphy, Head of Digital Product Management, GlobalData

• Panelist 1: Aimee Hogue, Director Supply Chain, Sutro Biopharma
• Panelist 2: Amber Bill, Associate Director, Sangamo Therapeutics  

Panelist 3: Burkard Kolb, Former Executive Director, CMC Operations, 89bio  (Genentech) 

• Aligning Supply Chain, CMC, Clinical Operations, Regulatory, Quality, and Finance to evaluate options, trade-offs, risk, and cost and align on an integrated path forward
• Establishing S&OP governance, ownership, and decision rights linking supply execution with financial planning to drive transparency, accountability, and aligned decisions
• Creating end-to-end visibility to identify constraints early, improve agility, mitigate risk, and maintain supply continuity across clinical and commercial programs

• From forecasting to continuous supply intelligence: why the real metric is decision latency, the time between a supply signal and a supply action, and how leading sponsors are collapsing it from weeks to hours

• The connected ecosystem in practice: how event-driven supply orchestration (IRT working in concert with eCOA, depots, couriers, and temperature data) turns thousands of small, automated decisions into fewer shipments, leaner stock, and uninterrupted patient dosing.

• You vs. the algorithm (live)